In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High
On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.
Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.
Climate Counts evaluates firms’ commitments in four areas:
- whether they have measured their carbon footprint
- if they reduced their impact on global warming
- if they have supported or blocked climate legislation or policy
- to what level they have publicly disclosed their climate actions
AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.
Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.
Energy Manager News
- ERC: Electricity Price Trends for the Week Ending June 26
- Final Energy Conservation Standards for Packaged Terminal Air Conditioners Mirror ASHRAE/IES Standard 90.1-2013
- Seeley International Acquires Coolerado
- Joule Assets Becomes Demand Response Provider in Texas
- Excalibur Energy Becomes Preferred Supplier for Facilities Management Firm
- Product Warranty Covers Both Insulated Roof Panels, Solar PV
- Combining Solar with Ground Heat Pump Is Energy, Cost Efficient
- Current Clamps Measure Energy for Small Businesses